NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
16.84
-0.27 (-1.58%)
At close: Apr 28, 2026, 4:00 PM EDT
17.50
+0.66 (3.92%)
After-hours: Apr 28, 2026, 4:35 PM EDT
NRC Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 138.64 | 137.39 | 143.06 | 148.58 | 151.57 | 147.95 | Upgrade
|
| Revenue Growth (YoY) | -1.88% | -3.96% | -3.72% | -1.97% | 2.44% | 11.01% | Upgrade
|
| Cost of Revenue | 52.96 | 52.37 | 56.93 | 56.02 | 57.05 | 52.35 | Upgrade
|
| Gross Profit | 85.68 | 85.02 | 86.13 | 92.57 | 94.52 | 95.6 | Upgrade
|
| Selling, General & Admin | 51.08 | 48.02 | 44.65 | 46.58 | 42.69 | 38.81 | Upgrade
|
| Operating Expenses | 59.33 | 55.64 | 50.67 | 52.48 | 47.96 | 44.86 | Upgrade
|
| Operating Income | 26.35 | 29.38 | 35.45 | 40.09 | 46.56 | 50.74 | Upgrade
|
| Interest Expense | -5.12 | -4.76 | -2.6 | -0.86 | -1.21 | -1.67 | Upgrade
|
| Interest & Investment Income | 0.13 | 0.11 | 0.13 | 0.82 | 0.17 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | -0.1 | -0.03 | -0.04 | -2.69 | 0 | Upgrade
|
| EBT Excluding Unusual Items | 21.29 | 24.63 | 32.95 | 40 | 42.83 | 49.1 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.12 | - | - | -0.12 | Upgrade
|
| Asset Writedown | -0.01 | -0.01 | -0.06 | -0.04 | -0.01 | -0.36 | Upgrade
|
| Other Unusual Items | -6.78 | -6.78 | -0.08 | - | - | - | Upgrade
|
| Pretax Income | 14.5 | 17.85 | 32.69 | 39.96 | 42.82 | 48.62 | Upgrade
|
| Income Tax Expense | 5.47 | 6.25 | 7.91 | 8.99 | 11.02 | 11.16 | Upgrade
|
| Net Income | 9.04 | 11.6 | 24.78 | 30.97 | 31.8 | 37.47 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.31 | 0.31 | 0 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Net Income to Common | 8.73 | 11.29 | 24.78 | 30.96 | 31.78 | 37.45 | Upgrade
|
| Net Income Growth | -62.68% | -53.19% | -19.98% | -2.61% | -15.12% | 0.55% | Upgrade
|
| Shares Outstanding (Basic) | 22 | 22 | 24 | 25 | 25 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 22 | 24 | 25 | 25 | 26 | Upgrade
|
| Shares Change (YoY) | -5.81% | -5.67% | -3.77% | -1.51% | -2.29% | -0.22% | Upgrade
|
| EPS (Basic) | 0.40 | 0.50 | 1.05 | 1.26 | 1.28 | 1.47 | Upgrade
|
| EPS (Diluted) | 0.39 | 0.50 | 1.04 | 1.25 | 1.27 | 1.46 | Upgrade
|
| EPS Growth | -62.25% | -51.92% | -16.80% | -1.57% | -13.01% | 0.69% | Upgrade
|
| Free Cash Flow | 17.43 | 15.74 | 19.18 | 22.33 | 26.43 | 40.83 | Upgrade
|
| Free Cash Flow Per Share | 0.79 | 0.70 | 0.81 | 0.91 | 1.05 | 1.59 | Upgrade
|
| Dividend Per Share | 0.400 | 0.520 | 0.480 | 0.480 | 0.840 | 0.480 | Upgrade
|
| Dividend Growth | -16.67% | 8.33% | - | -42.86% | 75.00% | 128.57% | Upgrade
|
| Gross Margin | 61.80% | 61.88% | 60.20% | 62.30% | 62.36% | 64.62% | Upgrade
|
| Operating Margin | 19.01% | 21.38% | 24.78% | 26.98% | 30.72% | 34.30% | Upgrade
|
| Profit Margin | 6.30% | 8.22% | 17.32% | 20.84% | 20.97% | 25.31% | Upgrade
|
| Free Cash Flow Margin | 12.57% | 11.46% | 13.41% | 15.03% | 17.44% | 27.60% | Upgrade
|
| EBITDA | 34.6 | 37 | 41.48 | 45.99 | 51.83 | 56.79 | Upgrade
|
| EBITDA Margin | 24.96% | 26.93% | 28.99% | 30.95% | 34.20% | 38.39% | Upgrade
|
| D&A For EBITDA | 8.25 | 7.62 | 6.02 | 5.9 | 5.28 | 6.05 | Upgrade
|
| EBIT | 26.35 | 29.38 | 35.45 | 40.09 | 46.56 | 50.74 | Upgrade
|
| EBIT Margin | 19.01% | 21.38% | 24.78% | 26.98% | 30.72% | 34.30% | Upgrade
|
| Effective Tax Rate | 37.69% | 35.00% | 24.19% | 22.50% | 25.73% | 22.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.